These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15660719)

  • 1. Neuroleptic malignant syndrome with promethazine.
    Mendhekar DN; Andrade C
    Aust N Z J Psychiatry; 2005; 39(1-2):113-4. PubMed ID: 15660719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome in catatonic schizophrenia with respiratory insufficiency--an interdisciplinary problem].
    Koberstein B; Balzer K; Eikmeier G; Hager W; Goebell H
    Med Klin (Munich); 1990 Mar; 85 Suppl 1():129-32. PubMed ID: 2342438
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome due to promethazine.
    Chan-Tack KM
    South Med J; 1999 Oct; 92(10):1017-8. PubMed ID: 10548178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of clozapine-induced neuroleptic malignant syndrome.
    Miller DD; Sharafuddin MJ; Kathol RG
    J Clin Psychiatry; 1991 Mar; 52(3):99-101. PubMed ID: 1672311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome associated with clozapine monotherapy.
    Thornberg SA; Ereshefsky L
    Pharmacotherapy; 1993; 13(5):510-4. PubMed ID: 8247922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment: Promethazine adverse events after implementation of a medication shortage interchange.
    Habib AS; Breen TW; Gan TJ
    Ann Pharmacother; 2005; 39(7-8):1370; author reply 1370-1. PubMed ID: 15956221
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of clozapine in a patient with a history of neuroleptic malignant syndrome.
    Stoudemire A; Clayton L
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):303-5. PubMed ID: 2577714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome with promethazine.
    Mendhekar DN; Andrade CR
    Aust N Z J Psychiatry; 2005 Apr; 39(4):310. PubMed ID: 15777370
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Catatonic dilemma". Therapy with lorazepam and clozapine].
    Lausberg H; Hellweg R
    Nervenarzt; 1998 Sep; 69(9):818-22. PubMed ID: 9789276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy.
    Bakri YN; Khan R; Subhi J; Kawi Z
    Gynecol Oncol; 1992 Feb; 44(2):189-90. PubMed ID: 1544597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two masters.
    Schneider CE
    Hastings Cent Rep; 2010; 40(1):9-10. PubMed ID: 20166509
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome precipitated by promethazine and lorazepam.
    Duggal HS
    Aust N Z J Psychiatry; 2001 Apr; 35(2):250-1. PubMed ID: 11284912
    [No Abstract]   [Full Text] [Related]  

  • 14. Catatonic schizophrenia: therapeutic challenges and potentially a new role for electroconvulsive therapy?
    Philbin D; Mulryan D; O'Grady M
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23897375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K; Warchala A
    Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine.
    Tarkkila P; Törn K; Tuominen M; Lindgren L
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):983-6. PubMed ID: 8848904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of Promethazine With Ondansetron for Treatment of Opioid- and Trauma-Related Nausea and Vomiting in Tactical Combat Casualty Care.
    Onifer DJ; Butler FK; Gross K; Otten EJ; Patton R; Russell RJ; Stockinger Z; Burrell E
    J Spec Oper Med; 2015; 15(2):17-24. PubMed ID: 26125161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritis.
    Desai D; Gupta K; Kumar R; Biswas A
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30100569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome: occurrence in a child after reconstructive surgery.
    Brown FE; Nierenberg DW; Nordgren RE; Taylor RM; Rozycki AA
    Plast Reconstr Surg; 1991 May; 87(5):961-4. PubMed ID: 2017509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
    Tenenbein M
    Pediatr Neurosci; 1985-1986; 12(3):161-4. PubMed ID: 3870437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.